{
    "2018-04-03": [
        [
            {
                "time": "",
                "original_text": "药明康德闪电过会 三年十倍的私有化奇迹",
                "features": {
                    "keywords": [
                        "药明康德",
                        "闪电过会",
                        "私有化",
                        "奇迹"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "东吴医药行业周观点：药明康德成为第二家“IPO快速通道”的独角兽公司 创新药主题迎来新一轮投资机会",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO快速通道",
                        "独角兽",
                        "创新药",
                        "投资机会"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]深度*行业*医药行业周报：溢价率处于13百分位 加配创新药械/服务/连锁药店",
                "features": {
                    "keywords": [
                        "强于大市",
                        "医药行业",
                        "溢价率",
                        "创新药械",
                        "服务",
                        "连锁药店"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业深度研究：医药市场认可提升 优选高景气子行业龙头",
                "features": {
                    "keywords": [
                        "买入评级",
                        "医药生物",
                        "市场认可",
                        "高景气",
                        "子行业龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "涨停揭秘：两市全线回落调整 超跌次新股迎涨停潮",
                "features": {
                    "keywords": [
                        "涨停",
                        "两市",
                        "回落调整",
                        "超跌次新股",
                        "涨停潮"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "机构：金融业让出全年最大IPO已成定局",
                "features": {
                    "keywords": [
                        "机构",
                        "金融业",
                        "IPO",
                        "定局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}